Otsuka Pharmaceutical Company, Limited

Educational Foundation Jichi Medical University

Masami Mizukoshi

Makoto Matsumoto

Masanori Kawasaki

Norimitsu Hariguchi

Yoshihiro Goto

Shigeto Yoshida

Yoshio Ohba

Masahiro Saito

Katsuya Inagaki

Kuniko Hirota

The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza; and methods for preventing and treating infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient; and methods for preventing and treating infectious diseases such as malaria and influenza comprising administrating the recombinant baculovirus to patients.

Recombinant baculovirus vaccine

A recombinant transfer vector capable of expressing a foreign gene fused to a viral gene under the control of dual promoters and a recombinant baculovirus, and methods for production thereof, as well as pharmaceuticals comprising the recombinant baculovirus as an active ingredient.

Growing community of inventors

Osaka, Japan

Masami Mizukoshi